Wellington Management Group LLP Has $247.08 Million Holdings in Option Care Health, Inc. $OPCH

Wellington Management Group LLP cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1.0% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 11,782,384 shares of the company’s stock after selling 115,083 shares during the quarter. Wellington Management Group LLP owned 7.87% of Option Care Health worth $247,077,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. Public Employees Retirement System of Ohio acquired a new stake in Option Care Health during the second quarter worth approximately $66,000. Bank of New York Mellon Corp acquired a new position in Option Care Health in the 2nd quarter valued at $19,600,000. Wedge Capital Management L L P NC raised its holdings in Option Care Health by 25.7% in the 2nd quarter. Wedge Capital Management L L P NC now owns 190,257 shares of the company’s stock valued at $3,990,000 after acquiring an additional 38,856 shares in the last quarter. Harbor Investment Advisory LLC bought a new stake in shares of Option Care Health during the 2nd quarter valued at $48,000. Finally, Central Pacific Bank Trust Division lifted its position in shares of Option Care Health by 18.9% during the 2nd quarter. Central Pacific Bank Trust Division now owns 13,829 shares of the company’s stock valued at $290,000 after acquiring an additional 2,200 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts recently commented on the company. Weiss Ratings cut Option Care Health from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday. Wall Street Zen raised shares of Option Care Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 1st. Zacks Research upgraded shares of Option Care Health from a “strong sell” rating to a “hold” rating in a research note on Monday, July 6th. UBS Group reissued a “buy” rating on shares of Option Care Health in a report on Tuesday, June 16th. Finally, Stephens restated an “equal weight” rating and issued a $24.00 target price (down from $30.00) on shares of Option Care Health in a research report on Friday, July 17th. Seven investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $29.92.

Option Care Health Price Performance

Shares of OPCH opened at $23.90 on Monday. Option Care Health, Inc. has a 52 week low of $18.01 and a 52 week high of $36.80. The stock has a market capitalization of $3.58 billion, a price-to-earnings ratio of 17.97, a PEG ratio of 1.38 and a beta of 0.65. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The stock has a fifty day moving average of $22.58 and a 200-day moving average of $25.17.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02. Option Care Health had a return on equity of 18.74% and a net margin of 3.68%.The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.42 billion. During the same quarter last year, the business posted $0.41 EPS. Option Care Health’s revenue for the quarter was up 1.9% on a year-over-year basis. Option Care Health has set its FY 2026 guidance at 1.850-1.920 EPS. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.69 earnings per share for the current fiscal year.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.